Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data

The combination of gemcitabine and dacarbazine has exhibited efficacy in terms of progression-free survival (PFS) and overall survival (OS) for aSTSs, albeit without robust confirmation from larger clinical trials. We conducted a retrospective study in a single institution involving aSTS patients tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-01, Vol.16 (2), p.267
Hauptverfasser:	Gurruchaga Sotés, Ibon, Gómez-Mateo, M Carmen, Ortega Izquierdo, María Eugenia, Martínez-Trufero, Javier
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antimitotic agents Antineoplastic agents Care and treatment Clinical medicine Clinical trials Dacarbazine Disease Gemcitabine Kinases Lymphocytes Medical prognosis Medical research Medicine, Experimental Metastasis Mortality Patients Sarcoma Statistical analysis Toxicity Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!